Literature DB >> 21336281

Navigating the kinome.

James T Metz1, Eric F Johnson, Niru B Soni, Philip J Merta, Lemma Kifle, Philip J Hajduk.   

Abstract

Although it is increasingly being recognized that drug-target interaction networks can be powerful tools for the interrogation of systems biology and the rational design of multitargeted drugs, there is no generalized, statistically validated approach to harmonizing sequence-dependent and pharmacology-dependent networks. Here we demonstrate the creation of a comprehensive kinome interaction network based not only on sequence comparisons but also on multiple pharmacology parameters derived from activity profiling data. The framework described for statistical interpretation of these network connections also enables rigorous investigation of chemotype-specific interaction networks, which is critical for multitargeted drug design.

Mesh:

Substances:

Year:  2011        PMID: 21336281     DOI: 10.1038/nchembio.530

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


  14 in total

1.  Shannon entropy--a novel concept in molecular descriptor and diversity analysis.

Authors:  J W Godden; J Bajorath
Journal:  J Mol Graph Model       Date:  2000-02       Impact factor: 2.518

Review 2.  Kinomics-structural biology and chemogenomics of kinase inhibitors and targets.

Authors:  Michal Vieth; Richard E Higgs; Daniel H Robertson; Michael Shapiro; Ellen A Gragg; Horst Hemmerle
Journal:  Biochim Biophys Acta       Date:  2004-03-11

Review 3.  Rational approaches to targeted polypharmacology: creating and navigating protein-ligand interaction networks.

Authors:  James T Metz; Philip J Hajduk
Journal:  Curr Opin Chem Biol       Date:  2010-07-06       Impact factor: 8.822

4.  Drug discovery: playing dirty.

Authors:  Simon Frantz
Journal:  Nature       Date:  2005-10-13       Impact factor: 49.962

Review 5.  Kinomics: characterizing the therapeutically validated kinase space.

Authors:  Michal Vieth; Jeffrey J Sutherland; Daniel H Robertson; Robert M Campbell
Journal:  Drug Discov Today       Date:  2005-06-15       Impact factor: 7.851

6.  Global mapping of pharmacological space.

Authors:  Gaia V Paolini; Richard H B Shapland; Willem P van Hoorn; Jonathan S Mason; Andrew L Hopkins
Journal:  Nat Biotechnol       Date:  2006-07       Impact factor: 54.908

7.  Systems chemical biology.

Authors:  Tudor I Oprea; Alexander Tropsha; Jean-Loup Faulon; Mark D Rintoul
Journal:  Nat Chem Biol       Date:  2007-08       Impact factor: 15.040

8.  Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.

Authors:  Paul Bamborough; David Drewry; Gavin Harper; Gary K Smith; Klaus Schneider
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

9.  Data completeness--the Achilles heel of drug-target networks.

Authors:  Jordi Mestres; Elisabet Gregori-Puigjané; Sergi Valverde; Ricard V Solé
Journal:  Nat Biotechnol       Date:  2008-09       Impact factor: 54.908

10.  The topology of drug-target interaction networks: implicit dependence on drug properties and target families.

Authors:  Jordi Mestres; Elisabet Gregori-Puigjané; Sergi Valverde; Ricard V Solé
Journal:  Mol Biosyst       Date:  2009-07-08
View more
  73 in total

1.  Comprehensive analysis of kinase inhibitor selectivity.

Authors:  Mindy I Davis; Jeremy P Hunt; Sanna Herrgard; Pietro Ciceri; Lisa M Wodicka; Gabriel Pallares; Michael Hocker; Daniel K Treiber; Patrick P Zarrinkar
Journal:  Nat Biotechnol       Date:  2011-10-30       Impact factor: 54.908

2.  Comprehensive characterization of the Published Kinase Inhibitor Set.

Authors:  Jonathan M Elkins; Vita Fedele; Marta Szklarz; Kamal R Abdul Azeez; Eidarus Salah; Jowita Mikolajczyk; Sergei Romanov; Nikolai Sepetov; Xi-Ping Huang; Bryan L Roth; Ayman Al Haj Zen; Denis Fourches; Eugene Muratov; Alex Tropsha; Joel Morris; Beverly A Teicher; Mark Kunkel; Eric Polley; Karen E Lackey; Francis L Atkinson; John P Overington; Paul Bamborough; Susanne Müller; Daniel J Price; Timothy M Willson; David H Drewry; Stefan Knapp; William J Zuercher
Journal:  Nat Biotechnol       Date:  2015-10-26       Impact factor: 54.908

3.  Thermodynamic Proxies to Compensate for Biases in Drug Discovery Methods.

Authors:  Sean Ekins; Nadia K Litterman; Christopher A Lipinski; Barry A Bunin
Journal:  Pharm Res       Date:  2015-08-27       Impact factor: 4.200

4.  Development of a highly selective c-Src kinase inhibitor.

Authors:  Kristoffer R Brandvold; Michael E Steffey; Christel C Fox; Matthew B Soellner
Journal:  ACS Chem Biol       Date:  2012-06-04       Impact factor: 5.100

5.  Development of Potent Pyrazolopyrimidinone-Based WEE1 Inhibitors with Limited Single-Agent Cytotoxicity for Cancer Therapy.

Authors:  Christopher J Matheson; Kimberly A Casalvieri; Donald S Backos; Philip Reigan
Journal:  ChemMedChem       Date:  2018-07-11       Impact factor: 3.466

6.  Quantifying structure and performance diversity for sets of small molecules comprising small-molecule screening collections.

Authors:  Paul A Clemons; J Anthony Wilson; Vlado Dančík; Sandrine Muller; Hyman A Carrinski; Bridget K Wagner; Angela N Koehler; Stuart L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-11       Impact factor: 11.205

7.  Enhancing Molecular Promiscuity Evaluation Through Assay Profiles.

Authors:  Sorin Avram; Ramona Curpan; Alina Bora; Cristian Neanu; Liliana Halip
Journal:  Pharm Res       Date:  2018-10-18       Impact factor: 4.200

8.  The contribution of VEGF signalling to fostamatinib-induced blood pressure elevation.

Authors:  M Skinner; K Philp; D Lengel; L Coverley; E Lamm Bergström; P Glaves; H Musgrove; H Prior; M Braddock; R Huby; J O Curwen; P Duffy; A R Harmer
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

9.  Kinome chemoproteomics characterization of pyrrolo[3,4-c]pyrazoles as potent and selective inhibitors of glycogen synthase kinase 3.

Authors:  Martin Golkowski; Gayani K Perera; Venkata Narayana Vidadala; Kayode K Ojo; Wesley C Van Voorhis; Dustin J Maly; Shao-En Ong
Journal:  Mol Omics       Date:  2018-02-12

10.  A novel multi-modal drug repurposing approach for identification of potent ACK1 inhibitors.

Authors:  Sharangdhar S Phatak; Shuxing Zhang
Journal:  Pac Symp Biocomput       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.